Clinical Trial Update: NEPH-ROSIS (NEPHrology in CirRhOSIS) Pilot Trial: A Trial to Treat Acute Kidney Injury Among Hospitalized Cirrhosis Patients [Phase 2, Phase 3]

View source ↗

Summary

NEPH-ROSIS, a Phase 2/3 pilot trial for treating acute kidney injury in hospitalized cirrhosis patients, has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cirrhosis
• Hepatorenal Syndrome
• Kidney Injury
• Portal Hypertension
• Prerenal Failure
• Tubular Necrosis

Snippet

Sponsor: University of California, San Francisco | Conditions: Acute Kidney Injury, Cirrhosis | Phase 2, Phase 3 | Status: TERMINATED